Overactive Bladder/Enuresis

GELNIQUE (Oxybutynin) 3% topical gel by Watson Pharmaceuticals

Gelnique Gel 3% for Overactive Bladder

Watson and Antares announced the launch of Gelnique (oxybutynin chloride) gel 3% for the treatment of overactive bladder (OAB) with symptoms of urinary incontinence, urgency, and frequency.

Upsher-Smith expands nationwide product recall

Upsher-Smith Laboratories is voluntarily expanding its previously announced recall of Jantoven (warfarin sodium) 3mg tablets to include additional products that were packaged on the same packaging line between May 17, 2010 and November 17, 2010.